Combining Latency Reversing Agents to Address the HIV Reservoir

Clinical trial NCT07384624 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07384624
Sponsor: Erasmus Medical Center
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HIV (Human Immunodeficiency Virus)HIV -1 Infection

Start date: 2026-04-01
Primary completion: 2028-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.